Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:12 PM
Ignite Modification Date:
2025-12-24 @ 7:12 PM
NCT ID:
NCT01379703
Eligibility Criteria:
Inclusion Criteria:
Patients infected by HIV-1 infection who are either:
* Antiretroviral treatment (ART) naive or
* Had failed or had been intolerant to one previous combined antiretroviral treatment (cART), not including a Protease inhibitor (PI) (first-line pretreated without a Protease inhibitor) or
* Had failed or had been intolerant to one previous antiretroviral treatment ART, including one Protease inhibitor (first-line pretreated with a Protease Inhibitor).
A ritonavir-boosted Protease inhibitor PI is considered as treatment with one Protease inhibitor PI.
Exclusion Criteria:
* Treatment with drugs at risk for interactions with lopinavir/ritonavir
* Uncontrolled AIDS defining disease
* Two or more previous Protease inhibitors (PIs)
* Participation in another study or clinical trial
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
2 Years
Study:
NCT01379703
Study Brief:
Protocol Section:
NCT01379703